Maryland SB778 regulates clinical research pharmacies and clinical trials by requiring permits and allowing certain ownership interests.
Maryland SB778 establishes regulations for clinical research pharmacies and clinical trials. The Board of Pharmacy must issue a permit for anyone to establish or operate a clinical research pharmacy in the state. A separate permit is required for each pharmacy. The bill also allows a health care provider to hold an ownership interest in a clinical research pharmacy under specific conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.